Y Zhang

机构：China Pharmaceutical University · ORCID：0000-0002-8803-519X

发表论文 9 篇 · 总被引 42 次 · h-index 3

代表论文

• EGFR tyrosine kinase inhibitor Almonertinib induces apoptosis and autophagy mediated by reactive oxygen species in non-small cell lung cancer cells (2021 · Human & Experimental Toxicology · 被引 27)
• [Chuanxiong Rhizoma inhibits brain metastasis of lung cancer through multiple active ingredients acting on multiple targets, pathways and biological functions]. (2021 · PubMed · 被引 6)
• [Isobavachalcone induces cell death through multiple pathways in human breast cancer MCF-7 cells]. (2022 · PubMed · 被引 5)
• Prenylterphenyllin, a regulator of P53, inhibits colorectal cancer progression through oxidative stress and energy metabolism pathway (2026 · Redox Biology · 被引 2)
• [AZD9291 suppresses proliferation and migration of nasopharyngeal carcinoma cells by inhibiting the PI3K-AKT-mTOR pathway]. (2022 · PubMed · 被引 2)
• Analysis of the Current Status of Parkour Course Offerings in Higher Education — A Case Study of Hubei University (2025 · Leisure Sports and Health)